1-8 of 8
Keywords: Treatment
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Skin Pharmacol Physiol (2015) 28 (5): 255–256.
Published Online: 27 May 2015
.... These endpoints were established for different adjuvant agents, but at that moment, rituximab was not considered. Rituximab is known for the long duration of its effect, and in most studies relapses have been reported later than 6 months after treatment. In our opinion, time to remission after rituximab treatment...
Journal Articles
Skin Pharmacol Physiol (2015) 28 (3): 159–166.
Published Online: 20 January 2015
... to placebo. The clinical efficacy of the new selective corticosteroid was not superior to placebo, although a dose-dependent improvement upon treatment was noticed without the onset of skin thinning. Patients (18-65 years old) with a diagnosis of AD were included. AD was defined as a documented history...
Journal Articles
Skin Pharmacol Physiol (2014) 27 (6): 303–310.
Published Online: 27 June 2014
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Inflammation Herbal medicine Phytomedicine Review Topical application Treatment...
Journal Articles
Skin Pharmacol Physiol (2013) 27 (Suppl. 1): 3–8.
Published Online: 13 November 2013
... differences, the key principles of acne treatment in the adult female do not differ significantly from those of other age groups. However, specific characteristics relating to the adult female should be considered when selecting a treatment regimen. 13 11 2013 © 2013 S. Karger AG, Basel 2013...
Journal Articles
Skin Pharmacol Physiol (2013) 27 (Suppl. 1): 9–17.
Published Online: 13 November 2013
... microscopy examinations of the follicular epithelium were performed after topical application of 20% AzA. Here treatment with AzA also resulted in a reduced thickness of the horny layer with a marked reduction in both number and size of keratohyalin granules [ 38 ]. The extent of the effect of AzA...
Journal Articles
Skin Pharmacol Physiol (2012) 25 (6): 313–318.
Published Online: 31 August 2012
..., most therapeutic approaches remain clinically unsatisfactory. Recently, injections with botulinum toxin A (BTA) were proposed for the treatment of established keloids in a clinical trial. In this study, we aimed to verify the effects of intralesional BTA for the treatment of therapy-resistant keloids...
Journal Articles
Skin Pharmacology and Applied Skin Physiology (2001) 14 (3): 129–135.
Published Online: 14 June 2001
...P.C.M. van de Kerkhof During the previous 10 years, important innovations have been developed in the treatment of psoriasis. Calcipotriol has been introduced in most countries already 10 years ago and more recently 2 other vitamin D 3 analogues have become available: calcitriol and tacalitol...
Journal Articles
Skin Pharmacology and Applied Skin Physiology (1998) 11 (1): 2–10.
Published Online: 01 April 1998
...P.C.M. van de Kerkhof Vitamin D 3 analogues have revolutionized the topical treatment of psoriasis during the last decade. The mode of action of this ligand for the vitamin D 3 receptor is via modulation of the transcription of genes with vitamin D 3 response elements in their promoter region...